Top compounds associated with response to CTC-260F20.3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.05
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.15 0.05
mRNA A-804598 CTRPv2 pan-cancer AAC -0.094 0.05
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.15 0.05
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.068 0.05
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.074 0.05
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.16 0.06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.06
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.07 0.07
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.072 0.07
Download CSV